Corient Private Wealth’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.18M Sell
9,282
-55,852
-86% -$8.03M ﹤0.01% 1558
2025
Q4
$2.37M Buy
65,134
+61,075
+1,505% +$8.18M ﹤0.01% 1440
2025
Q3
$487K Buy
4,059
+538
+15% +$68.2K ﹤0.01% 1804
2025
Q2
$465K Buy
3,521
+1,248
+55% +$169K ﹤0.01% 1739
2025
Q1
$316K Buy
2,273
+40
+2% +$6.21K ﹤0.01% 1827
2024
Q4
$346K Sell
2,233
-3,578
-62% -$605K ﹤0.01% 1820
2024
Q3
$1.06M Buy
5,811
+3,125
+116% +$463K ﹤0.01% 1379
2024
Q2
$319K Buy
2,686
+110
+4% +$11.6K ﹤0.01% 1869
2024
Q1
$276K Buy
2,576
+477
+23% +$47.4K ﹤0.01% 1935
2023
Q4
$209K Buy
+2,099
New +$205K ﹤0.01% 2053

Other funds holding ICUI

Corient Private Wealth's ICUI Position: Q1 2026 in Review

Corient Private Wealth reduced its ICU Medical (ICUI) stake by 86% in Q1 2026, selling an estimated $8.03M and leaving 9,282 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1558.

Corient Private Wealth first reported a position in ICUI in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.37M in Q4 2025. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • Corient Private Wealth held 9,282 shares of ICU Medical worth $1.18M as of Q1 2026.
  • Corient Private Wealth sold 55,852 ICU Medical shares in Q1 2026, an estimated $8.03M.
  • ICU Medical made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1558 holding.
  • Corient Private Wealth first reported a position in ICU Medical in Q4 2023 and has held it in 10 quarters since.
  • Corient Private Wealth's ICU Medical position peaked at $2.37M in Q4 2025.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.